Efficacy and Safety of PRO-155 (Zebesten Ofteno) on Inflammation of the Conjunctival Surface in Subjects With Grade I-III Pterygium vs Placebo.
Phase of Trial: Phase IV
Latest Information Update: 22 Nov 2019
Price : $35 *
At a glance
- Drugs PRO 155 (Primary) ; Hyaluronic acid
- Indications Pterygium
- Focus Therapeutic Use
- Acronyms PRO-155/IV
- Sponsors Laboratorios Sophia
- 30 Oct 2019 Status changed from recruiting to completed.
- 15 May 2018 New trial record